MedTrace Logo

Strategies for Delivering Anti-HIV Therapy in South Africa

NCT00080522 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 813

Last updated 2007-09-18

No results posted yet for this study

Summary

Providing effective anti-HIV therapy in developing countries is challenging. This study will evaluate new strategies for delivering anti-HIV medications to people in South Africa. These strategies include using specially trained nurses to administer therapy (rather than doctors), treating all HIV infected members of a household at the same time, and having community members observe patients taking their medications.

Conditions

  • HIV Infections

Interventions

BEHAVIORAL

Monitoring by HIV-trained primary care nurses

BEHAVIORAL

Community-based directly observed therapy (DOT)

DRUG

stavudine

DRUG

lamivudine

DRUG

efavirenz

DRUG

zidovudine

DRUG

didanosine

DRUG

lopinavir/ritonavir

Sponsors & Collaborators

  • National Institute of Allergy and Infectious Diseases (NIAID)

    lead NIH

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
3 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-02-28
Completion
2007-01-31

Countries

  • South Africa

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00080522 on ClinicalTrials.gov